Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study. - Manzi S; Bruce IN; Morand EF; Furie R; Tanaka Y; Kalunian KC; Askanase A; Puzio P; Khan E; Wissmar J; Song M; Lindholm C (Arthritis & rheumatology (Hoboken, N.J.), 2026)